This guidance sets out the circumstances in which it may be appropriate to offer a course of prophylactic antiviral medicine to patients with a serious underlying medical condition or who are pregnant during the H1N1 (swine flu) pandemic.
Related articles
-
HSJ KnowledgePartnership working and the flu pandemic
The H1N1 pandemic never reached the intensity feared, but the emergency response set in place has strengthened partnership working.
-
NewsSwine flu vaccine bill cost department £239m
The government spent £239m on the swine flu vaccine, official figures reveal.
-
NewsRise in intensive care beds occupied by flu patients
The number of flu cases being treated in critical care beds has increased by 66 per cent in the last week, according to figures released by the Department of Health.
More from News
-
NewsChair denies bullying and coercive behaviour
The outgoing chair of a hospital trust has denied that she was “bullying or coercive”, despite complaints from consultants.
-
NewsMaternity unit to be closed despite safety fears
An integrated care board has decided which of the five maternity units on its patch should close despite concerns from clinical leaders the move could increase deaths.
-
NewsLegal costs top £4m in bank vs hospital PFI case
Legal costs in a case brought on behalf of Lloyds Bank against an NHS trust in a row over fire safety have topped £4m, HSJ can reveal.
No comments yet